Search & Analyze

Molbio Diagnostics Ltd.

HealthcareMedical Equipment/Supplies/Accessories

www.molbiodiagnostics.com BSE: 544866NSE: MOLBIO

₹1,312.65BSE4.81%

16 Sep, 4:01 PM

₹1,312.65

₹15.69K Cr

94.17

11.03

15.36%

₹1,438.70

₹1,198.60

₹1,686.50

₹925.80

Customise metrics bar

Price Performance

Peer Comparison

Name
LENSKART LENSKART	677.40	181.89	1,17,820.60	0.00	228.43	273.43%	2,714.18	43.27%	12.55
POLY MEDICUR POLYMED	1,700.70	54.81	17,238.54	0.21	85.27	-8.39%	525.38	30.30%	14.05
Molbio Diagnostics Ltd. MOLBIO	1,312.65	94.17	15,688.77	0.00	52.74	320.28%	408.38	309.57%	19.79
3BBLACKBIO 3BBLACKBIO	1,291.00	20.94	1,108.02	0.37	8.98	-28.99%	33.49	50.62%	26.03
LAXMIDENTL LAXMIDENTL	195.15	35.25	1,073.90	0.00	10.32	23.83%	74.70	13.87%	24.97
GKB OPHTHA GKB	62.50	10.48	31.50	0.00	1.85	387.99%	33.04	2.28%	8.82

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2025	Jun 2026
	99.71	408.38
Expenses	114.96	307.79
	-15.26	100.58
	-15.30%	24.63%
	0.76	3.10
Interest	3.61	10.70
	12.32	17.08
	-31.28	75.91
	23.45%	30.52%
	-23.71	58.75
	-10.51	5.21

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
INCOME :
	332.46	836.56	1,020.42	1,445.69
	332.46	836.56	1,020.42	1,445.69
EXPENDITURE :
Increase/Decrease in Stock	-43.03	19.68	-22.47	1.29
Raw Material Consumed	186.30	320.75	437.31	574.89
Power & Fuel Cost	6.47	7.44	10.01	11.60
Employee Cost	49.73	63.89	102.79	145.23
Other Manufacturing Expenses	15.42	27.06	43.66	56.24
General and Administration Expenses	30.26	42.23	52.77	79.65
Selling and Distribution Expenses	28.76	67.01	97.79	208.02
Miscellaneous Expenses	15.39	54.33	36.33	47.35
	289.30	602.38	758.20	1,124.24
Operating Profit (Excl OI)	43.16	234.18	262.22	321.44
	4.95	4.10	7.52	9.48
	48.11	238.28	269.74	330.93
Interest	6.85	14.45	17.66	33.47
PBDT	41.26	223.83	252.08	297.46
	31.72	41.01	44.55	63.64
Profit Before Taxation & Exceptional Items	9.54	182.83	207.53	233.82
Exceptional Income / Expenses		-53.17	-11.13	-0.49
	9.54	129.64	194.43	231.14
Provision for Tax	12.99	46.10	55.85	67.00
	-3.45	83.54	138.58	164.14
Extra items	0.00	0.00	0.00	0.00
Minority Interest	2.72	18.41	6.52	2.45
Consolidated Net Profit	-0.73	101.95	145.10	166.59
Profit Balance B/F	518.95	518.39	620.29	764.65
Appropriations	518.23	620.34	765.40	931.25
	-3.22	452.32	64.32	14.77
Adjusted EPS	-0.06	9.05	12.86	14.77

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	2.25	2.25	2.26	11.28
Share Warrants & Outstandings	0.35	0.35
Total Reserves	718.88	820.78	966.14	1,158.06
Reserve excluding Revaluation Reserve	718.88	820.78	966.14	1,158.06
Revaluation reserve	0.00	0.00	0.00	0.00
	721.48	823.38	968.39	1,169.34
Minority Interest	15.86	5.46	-1.11	139.44
Secured Loans	0.99	15.12	6.14	212.41
Deferred Tax Assets / Liabilities	-5.18	-26.01	-46.65	-18.44
Other Long Term Liabilities	31.55	29.33	42.11	27.20
Long Term Provisions	1.53	1.90	4.05	9.57
Total Non-Current Liabilities	28.88	20.34	5.66	230.74
Trade Payables	85.52	93.99	230.21	199.50
Other Current Liabilities	53.89	78.14	84.11	144.37
Short Term Borrowings	105.74	149.00	105.75	180.23
Short Term Provisions	12.40	21.64	21.59	33.26
Total Current Liabilities	257.55	342.76	441.66	557.36
Total Liabilities	1,023.77	1,191.94	1,414.61	2,096.87
Gross Block	388.57	414.61	484.61	787.33
Less: Accumulated Depreciation	102.36	158.22	195.10	250.96
Net Block	286.21	256.39	289.51	536.37
Capital Work in Progress		1.58	27.33	11.32
Non Current Investments	6.01	5.99	45.57	5.98
Long Term Investment	6.01	5.99	45.57	5.98
Long Term Loans & Advances	78.78	48.57	93.83	81.94
Other Non Current Assets	30.68	23.29	28.54	76.42
Total Non-Current Assets	407.03	368.78	484.78	712.03
Inventories	347.02	315.14	435.91	449.26
Sundry Debtors	188.76	425.45	271.66	408.74
Cash and Bank	7.24	22.11	129.05	367.11
Other Current Assets	11.73	8.75	6.70	19.67
Short Term Loans and Advances	56.69	51.71	86.50	140.07
Total Current Assets	611.42	823.16	929.83	1,384.84
Net Current Assets (Including Current Investments)	353.88	480.40	488.17	827.48
Total Assets	1,023.77	1,191.94	1,414.61	2,096.87
Contingent Liabilities	58.69	76.06	110.61	168.74
Total Debt	108.44	174.58	123.16	412.64
	3,199.33	3,651.42	429.25	103.70
Adjusted Book Value	63.99	73.03	85.85	103.70

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
	9.54	129.64	194.43	231.14
Adjustment	37.52	143.49	90.68	121.69
Changes In working Capital	55.22	-220.10	81.86	-231.76
Cash Flow after changes in Working Capital	102.28	53.04	366.97	121.07
Cash Flow from Operating Activities	64.13	9.57	287.10	50.39
Cash Flow from Investing Activities	-39.73	-45.01	-122.65	-93.22
Cash Flow from Financing Activitie	18.24	-31.55	-26.15	276.07
Net Cash Inflow / Outflow	42.64	-66.99	138.30	233.23
Opening Cash & Cash Equivalents	-50.72	-8.08	-75.07	63.23
Cash & Cash Equivalent on Amalgamation / Take over / Merger				24.49
Effect of Foreign Exchange Fluctuations				14.82
Closing Cash & Cash Equivalent	-8.08	-75.07	63.23	335.77

Ratios

Valuation

94.17

11.03

47.55

10.85

14.46

123.42

Profitability

15.36

19.79

9.35

22.23

11.35

Leverage & Liquidity

0.35

2.48

7.91

Returns

0.00

0.82

Shareholding Pattern

Numbers in percentages

Particulars	Aug '26
	41.29
	17.88
	40.82
	58.71
No. of Shareholders	2,33,544

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-09-01	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcareMedical Equipment/Supplies/Accessories

Molbio Diagnostics Ltd. operates in the Healthcare sector under the Medical Equipment/Supplies/Accessories industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

7 members across the board and senior leadership

Sriram Natarajan

Executive Director & Chief Executive Officer

₹2.44 Cr

Mar '26

Chandrasekhar Bhaskaran Nair

Executive Director & Chief Technology Officer

—

Sangeetha Sriram

Executive Director - Operations

₹1.44 Cr

Mar '26

Arun Kumar Jha

Non Executive Independent Director

₹15.00 L

Mar '26

Balram Bhargava

Non Executive Independent Director

₹15.00 L

Mar '26

Nupur Garg

Non Executive Independent Director

₹15.00 L

Mar '26

Darshan Karekar

Company Secretary & Compliance Officer

—

MOLBIO Latest News

News

3 of 3 articles

EQUITY7 Sept 2026 · 11:26

Molbio Diagnostics informs about press release

EQUITY17 Aug 2026 · 10:47

Molbio Diagnostics lists with 21% premium on the BSE

The scrip is currently trading at Rs. 1018.00, up by 211.00 points or 26.15% from its issue price

IPO7 Aug 2026 · 16:12

Molbio Diagnostics coming with IPO to raise up to Rs 950.03 crore

The issue will open for subscription on August 10, 2026 and will close on August 12, 2026

MOLBIO

₹1,312.65

-4.81%